Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR.

摘要

Several studies have analyzed the role of allogeneic BMT (alloBMT) in adult patients with acute lymphoblastic leukemia (ALL) in first CR in comparison with chemotherapy and/or autologous transplant. However, there are lack of information on long-term follow-up and complications in these patients. The patients treated with alloBMT or chemotherapy alone may have a different spectrum of long-term complications.